Ticker brief

BCRX

last close
·
1 day
·
14 days
·
mkt cap
·
signals 14d
10
authors 14d
7
crowd 14d
+1.5σ

No price history on file for this name (likely non-equity or unlisted) — the “since then” column below stays blank.

Sentiment — last 14 days
daily mean sentiment, 2026-08-19 → 2026-08-28 · now +0.12 (−1 bearish … +1 bullish)
Who spoke7
authorgradetrader scoresignalsmean sent
@TradeIdeasLLCC·4+0.00
@EmmanuelInvestC-1.111+0.50
@PersimmonTIA-0.571+0.50
@aljehaniC-2.591+0.50
@OzmosiHealthC·1+0.50
@StockSwingAlertC-2.211+0.25
@CNBCC+1.091+0.25
Recent signals10of 10 in 14d — receipts included
date (PT)authorsentwhat they saidsince thenreceipt
2026-08-28@TradeIdeasLLC+0.00Publishes a broad swing-setup watchlist with price alerts but no explicit entries or directional stances.·
2026-08-28@CNBC+0.25BioCryst's profitability supports plans to acquire more rare-disease drugs.·
2026-08-27@StockSwingAlert+0.25Flags a BCRX trigger around a 9/20 moving-average cross while referencing an earlier CABA idea.·
2026-08-26@TradeIdeasLLC+0.00Lists swing setups and price alerts without stating entries or direction; extraction is capped at six tickers.·
2026-08-25@OzmosiHealth+0.50Reports Japanese approval of ORLADEYO for pediatric HAE patients.·
2026-08-25@aljehani+0.50Reports Japanese approval of ORLADEYO for pediatric hereditary angioedema·
2026-08-25@PersimmonTI+0.50Japan approved named treatments from four biotech companies.·
2026-08-25@EmmanuelInvest+0.50Japan approved ORLADEYO for younger pediatric hereditary-angioedema patients.·
2026-08-20@TradeIdeasLLC+0.00Daily swing-setup watchlist with price alerts but no stated entries or direction.·
2026-08-19@TradeIdeasLLC+0.00Daily swing-setup watchlist with price alerts but no stated entries or direction.·

“Since then” = price move from the close on the signal's date (PT) to the latest close — what happened after they said it, not a backtest. A — means no trading session has closed since the signal yet. Sentiment is our extracted per-tweet score, −1…+1.